GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD.

Altre lingue Guizhou Bailing Group Pharmaceutical Co., Ltd.

Azioni

002424

CNE100000PY3

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
6,38 ^CNY	+0,31%		-2,45%	-21,33%

02/02	Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) annuncia un riacquisto di azioni per un valore di 200 milioni di CNY.	CI
02/02	Guizhou Bailing Group Pharmaceutical Co., Ltd. autorizza un piano di riacquisto.	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.	02/04
Guizhou Bailing Group Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.	02/02
Guizhou Bailing Group Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	02/02
Bailing Group Pharma Gets Green Light for Clinical Trial of New Hepatitis B Drug	28/12
China steel association says EU carbon tax a new trade barrier, calls for more talks	03/11
Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
China’s Steel Consumption Falls 1.5% in January-September Period	25/10/23
China steel supply needs adjusting, industry official says	24/10/23
La UE pondrá en marcha la primera fase del impuesto fronterizo sobre emisiones de CO2	13/09/23
EU to launch first phase of world-first CO2 border tax	13/09/23
Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23
Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.	10/07/23
Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback announced on January 9, 2023 has closed with 12,096,900 shares, representing 0.87% for CNY 100.01 million.	07/07/23
Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.	04/07/23
Guizhou Bailing Group Pharmaceutical Co., Ltd. Announces Management Appointments	06/06/23
Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.	03/04/23
Zhejiang Futures Co., Ltd completed the acquisition of 11.17% stake in Guizhou Bailing Group Pharmaceutical Co., Ltd. from Jiang Wei.	31/03/23
Zhejiang Futures Co., Ltd agreed to acquire a 11.17% stake in Guizhou Bailing Group Pharmaceutical Co., Ltd. from Jiang Wei for approximately CNY 210 million.	01/03/23
GZ Bailing Buys Ownership of Traditional Chinese Drug for 20 Million Yuan; Shares Rose 3%	16/01/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Guizhou Bailing Group Pharmaceutical Co., Ltd.

Azioni

002424

CNE100000PY3

Altre lingue

Filtri